Celator Pharma Balance Sheet - Quarterly (NASDAQ:CPXX)

Add to My Stocks
$30.24 $0 (0%) CPXX stock closing price Jul 14, 2016 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Celator Pharma stock analysis. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Celator Pharma stock analysis. Quarterly results are typically accompanied with the company releasing financial statements. The balance sheet shows total liabilities of $16.77M and shareholders equity of $52.63M. Celator Pharma revenue and Celator Pharma operating cash flow are important in understanding the financial capacity of the company.

View and download Celator Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Fiscal year is Jan - Dec2016 Q12015 Q4
Marketable Securities--
Raw Materials--
Work In Progress--
Finished Goods--
Notes Receivable--
Other Current Assets--
Total Current Assets
Property Plant & Equipment2.15M2.15M
Accumulated Depreciation1.34M1.29M
Net Property Plant & Equipment
Investment & Advances--
Other Non-Current Assets--
Deferred Charges--
Deposits & Other Assets--
Total Assets
Notes Payable--
Accounts Payable--
Current Portion Long-Term Debt-5.37M
Current Portion Capital Leases--
Accrued Expenses2.08M2.37M
Income Taxes Payable--
Other Current Liabilities--
Total Current Liabilities
Deferred Taxes/Income-1.02M
Convertible Debt--
Long-Term Debt12.83M9.49M
Non-Current Capital Leases--
Other Long-Term Liabilities1.02M-
Total Liabilities
Minority Interest--
Preferred Stock--
Common Stock Net--
Capital Surplus226.85M175.22M
Retained Earnings-174.21M-168.68M
Treasury Stock--
Other Liabilities-0.05M-0.05M
Shareholders Equity52.63M6.53M
Total Liabilities & Shareholders Equity69.4M25.63M
All figures in USD. M: Millions of USD, B: Billions of USD.

Click here to view our Akorn financial analysis

Looking at Celator Pharma historical stock prices and the current Celator Pharma stock price can tell you how the stock price has moved, whereas the Celator Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the Celator Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Celator Pharma had total assets of $69.4M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. CPXX stock had total liabilities of $16.77M for the quarter 2016 Q1.

Quarterly Balance Sheets For Celator Pharmaceuticals Inc Peers

Akorn balance sheet, CTI BioPharma balance sheet, Relypsa balance sheet